Cipher Pharmaceuticals Inc. (NASDAQ: CPHR; TSX:CPH) ("Cipher" or "the Company") today announced it has strengthened its product pipeline by acquiring the worldwide rights to three products from Astion ...

MISSISSAUGA, ON, Jan. 28, 2026 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced that Health Canada has accepted for review Cipher's new drug ...

Please provide your email address to receive an email when new articles are posted on . Cipher Pharmaceuticals announced it has acquired three products from Astion Pharma that are focused on ...

Good morning, ladies and gentlemen. Thank you for standing by. Welcome to the Cipher Pharmaceuticals quarterly conference call for the company's Full Year and Q4 2024 results. [Operator Instructions].

Craig Mull, Interim CEO, commented: "Having achieved our goal of doubling Cipher's revenue and earnings in 2025, we are focused on securing Cipher's next leg of growth in 2026. We continue to dedicate ...